Magnetic resonance imaging (MRI) plays a crucial role in oncology in terms of tumor characterization, staging, presurgical planning, therapy monitoring, and follow-up. Although oncology has become an especially hot topic recently in women’s health and breast cancer, men’s health should not be forgotten. Case in point, about one out of six men will be diagnosed with prostate cancer during his lifetime. After lung cancer, prostate cancer is the second leading cause of cancer death in American men¹. Siemens offers a comprehensive and state-of-the-art solution to facilitate the detection of prostate cancer. 

Furthermore, Siemens offers Tim^® (Total imaging matrix) technology, which provides unprecedented flexibility, accuracy, and speed. Tim's light-weight Matrix coils can be combined to suit the patient’s anatomy for any clinical indication. For the different prostate imaging purposes, a wide range of coils are offered for 1.5 Tesla and 3 Tesla systems. The Spine Matrix coil, Body Matrix coil and the endorectal coil can be combined. In addition, the 32-channel body coil provides excellent image quality in even shorter examination times.

syngo TimCT Oncology joins Siemens comprehensive oncology solutions and offers continuous table movement for extended Field of View (FoV) imaging as well as comprehensive staging for increased workflow. For example, a pelvic exam can be completed in as little as 20 minutes. syngo TimCT Oncology reduces the need for rescheduling multiple exams on other modalities by offering one complete exam on one system.
Additionally, with applications such as syngo SPACE and syngo REVEAL, imaging processes are carried out much faster and with increased accuracy. Prostate MRS (MR spectroscopy) provides information about the metabolic composition of a lesion. It enables tissue characterisation and provides essential information for treatment planning and follow up.